Insider · CIK 0001313516

JORDEN DAVID EMERSON

Reports to the SEC for 4 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001313516

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-28	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+7,984 sh	$1.09	+$8,694.576	2,070,000
2026-08-28	AURXNuo Therapeutics, Inc.P Purchase	Director, CEO/CFO	PPurchase	+7,984 sh	$1.09	+$8,694.576	2,070,000
2026-08-27	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+789 sh	$1.07	+$844.23	2,062,016
2026-08-27	AURXNuo Therapeutics, Inc.P Purchase	Director, CEO/CFO	PPurchase	+789 sh	$1.07	+$844.23	2,062,016
2026-06-30	AURXNuo Therapeutics, Inc.M Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	+163K sh	$1.00	+$163K	2,222,119
2026-06-30	AURXNuo Therapeutics, Inc.F Tax Payment	Director, CEO/CFO	FTax Payment	−161K sh	$1.01	−$163K	2,061,227
2026-06-30	AURXNuo Therapeutics, Inc. · Option to purchase common stockM Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	−163K sh	—	—	0
2026-06-29	AURXNuo Therapeutics, Inc. · Option to purchase common stockA Award	Director, CEO/CFO	AAward	+125K sh	—	—	125,000
2026-06-05	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+13.2K sh	$1.10	+$14.5K	2,085,000
2026-01-01	AURXNuo Therapeutics, Inc.M Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	+125K sh	$0.40	+$50K	2,071,755
2026-01-01	AURXNuo Therapeutics, Inc.F Tax Payment	Director, CEO/CFO	FTax Payment	−25.4K sh	$1.97	−$50K	2,046,374
2025-11-28	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−200K sh	$1.50	−$300K	1,946,755
2025-08-01	AURXNuo Therapeutics, Inc.M Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	+100K sh	$0.40	+$40K	2,075,358
2025-08-01	AURXNuo Therapeutics, Inc.M Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	+92.7K sh	$0.40	+$37.1K	2,168,068
2025-08-01	AURXNuo Therapeutics, Inc.F Tax Payment	Director, CEO/CFO	FTax Payment	−21.3K sh	$1.74	−$37.1K	2,146,755
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−30K sh	$1.50	−$45K	2,107,858
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−30K sh	$1.50	−$45K	2,077,858
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−27K sh	$1.50	−$40.5K	2,050,858
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−20K sh	$1.50	−$30K	2,030,858
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−20K sh	$1.50	−$30K	2,010,858
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−13.5K sh	$1.50	−$20.3K	1,997,358
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−10K sh	$1.50	−$15K	1,987,358
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−7,000 sh	$1.50	−$10.5K	1,980,358
2022-11-09	AURXNuo Therapeutics, Inc.S Sale	Director, CEO/CFO	SSale	−5,000 sh	$1.50	−$7,500	1,975,358
2022-04-29	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+10.5K sh	$1.00	+$10.5K	2,137,858
2022-03-04	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, CEO/CFO	AAward	+66.7K sh	—	—	66,672
2022-03-04	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, CEO/CFO	AAward	+125K sh	—	—	125,000
2021-12-30	AURXNuo Therapeutics, Inc.M Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	+1.14M sh	$0.20	+$228K	2,127,326
2021-12-30	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockM Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	−1.14M sh	—	—	0
2021-12-06	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockJ Other	Director, CEO/CFO	JOther	−160K sh	—	—	1,137,635
2021-12-01	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockA Award	Director, CEO/CFO	AAward	+1.3M sh	—	—	1,297,635
2021-12-01	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockD Disposition to Issuer	Director, CEO/CFO	DDisposition to Issuer	−900K sh	—	—	0
2021-12-01	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockD Disposition to Issuer	Director, CEO/CFO	DDisposition to Issuer	−398K sh	—	—	0
2020-10-05	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+300K sh	$0.40	+$120K	857,146
2020-10-05	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+82.5K sh	$0.40	+$33K	939,691
2020-10-05	AURXNuo Therapeutics, Inc.A Award	Director, CEO/CFO	AAward	+50K sh	$0.40	+$20K	989,691
2020-10-05	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockA Award	Director, CEO/CFO	AAward	+398K sh	—	—	397,635
2020-10-05	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockD Disposition to Issuer	Director, CEO/CFO	DDisposition to Issuer	−45K sh	—	—	0
2020-10-05	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockA Award	Director, CEO/CFO	AAward	+900K sh	—	—	900,000
2019-12-06	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockA Award	Director, CEO/CFO	AAward	+30K sh	—	—	45,000
2019-11-15	AURXNuo Therapeutics, Inc. · Warrants to purchase Common StockA Award	Director, CEO/CFO	AAward	+15K sh	—	—	15,000
2019-01-01	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, CEO/CFO	AAward	+125K sh	—	—	125,000
2018-12-31	AURXNuo Therapeutics, Inc. · Option to purchase common stockM Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	−125K sh	—	—	0
2018-08-09	AURXNuo Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, CEO/CFO	AAward	+193K sh	—	—	192,710
2018-08-09	AURXNuo Therapeutics, Inc. · Option to purchase common stockM Exercise/Conversion	Director, CEO/CFO	MExercise/Conversion	−193K sh	—	—	0
2017-08-10	AURXNuo Therapeutics, Inc.P Purchase	Director, CEO/CFO	PPurchase	+248K sh	$0.22	+$55K	557,146
2017-06-14	PLx Pharma Winddown Corp.P Purchase	Acting Chief Financial Officer, 10% Owner	PPurchase	+32.7K sh	$6.88	+$225K	151,913
2017-06-14	PLx Pharma Winddown Corp.WarrantP Purchase	Acting Chief Financial Officer, 10% Owner	PPurchase	+32.7K sh	—	—	32,727
2017-04-19	PLx Pharma Winddown Corp.A Award	Acting Chief Financial Officer, 10% Owner	AAward	+119K sh	—	—	119,186
2017-04-19	PLx Pharma Winddown Corp.OptionsA Award	Acting Chief Financial Officer, 10% Owner	AAward	+33.8K sh	—	—	33,753

Recent filings

Accepted (ET)
Aug 314/A
JORDEN DAVID EMERSON0001437749-26-029257
SEC(opens sec.gov)
Aug 284
JORDEN DAVID EMERSON0001437749-26-029236
SEC(opens sec.gov)
Jul 24
JORDEN DAVID EMERSON0001437749-26-022665
SEC(opens sec.gov)
Jun 54
JORDEN DAVID EMERSON0001437749-26-019768
SEC(opens sec.gov)
Jan 54
JORDEN DAVID EMERSON0001437749-26-000431
SEC(opens sec.gov)
Dec 34
JORDEN DAVID EMERSON0001437749-25-036821
SEC(opens sec.gov)
Aug 44
JORDEN DAVID EMERSON0001437749-25-024497
SEC(opens sec.gov)
Nov 144
JORDEN DAVID EMERSON0001437749-22-027386
SEC(opens sec.gov)

Companies

Address

C/O NUO THERAPEUTICS, INC. 8285 EL RIO, SUITE190

HOUSTON, TX, 77054